184 related articles for article (PubMed ID: 31949294)
1. Berberine derivatives with a long alkyl chain branched by hydroxyl group and methoxycarbonyl group at 9-position show improved anti-proliferation activity and membrane permeability in A549 cells.
Liu Y; Zhu KX; Cao L; Xie ZF; Gu M; Lü W; Li JY; Nan FJ
Acta Pharmacol Sin; 2020 Jun; 41(6):813-824. PubMed ID: 31949294
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Effects of Honokiol via Mitochondrial Dysfunction Are Strongly Enhanced by the Mitochondria-Targeting Carrier Berberine.
Shi X; Zhang T; Lou H; Song H; Li C; Fan P
J Med Chem; 2020 Oct; 63(20):11786-11800. PubMed ID: 32996316
[TBL] [Abstract][Full Text] [Related]
4. Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line.
Kalaiarasi A; Anusha C; Sankar R; Rajasekaran S; John Marshal J; Muthusamy K; Ravikumar V
J Agric Food Chem; 2016 Dec; 64(50):9542-9550. PubMed ID: 27936791
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment and NIR laser dual-responsive release of berberine 9-O-pyrazole alkyl derivative loaded in graphene oxide nanosheets for chemo-photothermal synergetic cancer therapy.
Du P; Yan J; Long S; Xiong H; Wen N; Cai S; Wang Y; Peng D; Liu Z; Liu Y
J Mater Chem B; 2020 May; 8(18):4046-4055. PubMed ID: 32248212
[TBL] [Abstract][Full Text] [Related]
6. 8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo.
Xiao Y; Tian C; Huang T; Han B; Wang M; Ma H; Li Z; Ye X; Li X
Life Sci; 2018 Jan; 192():259-269. PubMed ID: 29138118
[TBL] [Abstract][Full Text] [Related]
7. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and Structure-Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives.
Wang B; Deng AJ; Li ZH; Wang N; Qin HL
Molecules; 2020 Apr; 25(8):. PubMed ID: 32325679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: a lipophilic substitute role.
Lo CY; Hsu LC; Chen MS; Lin YJ; Chen LG; Kuo CD; Wu JY
Bioorg Med Chem Lett; 2013 Jan; 23(1):305-9. PubMed ID: 23182088
[TBL] [Abstract][Full Text] [Related]
10. Insight on Structural Modification, Cytotoxic or Anti-Proliferative Activity, Structure-Activity Relationship of Berberine Derivatives.
Yin M; Mou J; Sun L; Deng Y; Ren X
Med Chem; 2023; 19(9):823-837. PubMed ID: 37016520
[TBL] [Abstract][Full Text] [Related]
11. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
[TBL] [Abstract][Full Text] [Related]
12. Solution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexes.
Ferraroni M; Bazzicalupi C; Papi F; Fiorillo G; Guamán-Ortiz LM; Nocentini A; Scovassi AI; Lombardi P; Gratteri P
Chem Asian J; 2016 Apr; 11(7):1107-15. PubMed ID: 26865223
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and In Vitro Photocytotoxicity of 9-/13-Lipophilic Substituted Berberine Derivatives as Potential Anticancer Agents.
Lin HJ; Ho JH; Tsai LC; Yang FY; Yang LL; Kuo CD; Chen LG; Liu YW; Wu JY
Molecules; 2020 Feb; 25(3):. PubMed ID: 32033326
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Potential of Berberine and Cinnamic Acid against Solid Ehrlich Carcinoma in Mice.
Almeer RS; Aref AM; Hussein RA; Othman MS; Abdel Moneim AE
Anticancer Agents Med Chem; 2019; 19(3):356-364. PubMed ID: 30451117
[TBL] [Abstract][Full Text] [Related]
16. Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells.
Skonieczna M; Hudy D; Poterala-Hejmo A; Hejmo T; Buldak RJ; Dziedzic A
Anticancer Agents Med Chem; 2019; 19(9):1161-1171. PubMed ID: 30950357
[TBL] [Abstract][Full Text] [Related]
17. Cellular delivery and enhanced anticancer activity of berberine complexed with a cationic derivative of γ-cyclodextrin.
Popiołek I; Niziołek A; Kamiński K; Kwolek U; Nowakowska M; Szczubiałka K
Bioorg Med Chem; 2019 Apr; 27(7):1414-1420. PubMed ID: 30808605
[TBL] [Abstract][Full Text] [Related]
18. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
19. Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Wang S; An J; Dong W; Wang X; Sheng J; Jia Y; He Y; Ma X; Wang J; Yu D; Jia X; Wang B; Yu W; Liu K; Zhao Y; Wu Y; Zhu W; Pan Y
Int J Nanomedicine; 2020; 15():7951-7965. PubMed ID: 33116511
[TBL] [Abstract][Full Text] [Related]
20. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
